TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
DMRA

Damora Therapeutics, Inc.

Healthcare · Biotechnology

20.20$ -2.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Damora Therapeutics, Inc. (DMRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 544 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DMRA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
50 38 32 27 23 17 15 14 11 261 535 544
47 37 31 25 21 17 13 12 9.8 260 535 544
23 21 21 23 20 14 12 10 7.6 258 533 541
44 33 27 23 20 14 12 10 7.6 258 533 541
1.2 1.7 1.7 1.7 1.2 0.9 0.9 1.0 1.0 0.9 0.9 0.9
13 5.9 4.3 3.7 2.4 2.7 3.0 4.1 4.1 20 25 28
13 5.8 4.3 3.7 2.4 1.2 1.6 2.6 2.6 20 24 28
0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 – –
4.5 1.7 1.7 0.7 0.5 0.4 0.4 0.8 0.5 0.4 0.8 3.5
37 32 28 24 21 14 12 9.6 6.7 240 510 516
-250 -256 -262 -267 -271 -278 -280 -283 -287 -487 -515 -546
1.1 1.1 1.1 1.1 1.1 1.3 1.3 1.3 1.3 1.7 34 61

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?